重慶建工(600939.SH):擬將持有的建工威特65%的股權公開掛牌轉讓
格隆匯 6 月 19日丨重慶建工(600939.SH)公佈,公司第四屆董事會第十四次會議召開,審議通過了《重慶建工威特物業管理有限公司混合所有制改革方案》;
為提高所屬全資子公司重慶建工威特物業管理有限公司(“建工威特”)物業管理水平和市場競爭力,根據重慶市委、市政府、市國資委國企國資改革的相關文件精神,結合企業實際,公司董事會同意將持有的建工威特65%的股權在重慶產權聯合交易所公開掛牌轉讓,以引入戰略投資者,把建工威特改製為混合所有制企業。此次股權轉讓將以經評估後資產淨值的65%作為掛牌底價。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.